ticlopidine has been researched along with cysteine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bynagari, YS; Ding, Z; Jakubowski, JA; Kunapuli, SP; Mada, SR | 1 |
| Amunugama, H; Cooper, N; Hollenberg, PF; Ney, S; Zhang, H | 1 |
1 review(s) available for ticlopidine and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for ticlopidine and cysteine
| Article | Year |
|---|---|
Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y12 receptor when interacting with antagonists.
Topics: Blood Platelets; Clopidogrel; Cysteine; Dimerization; Humans; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine | 2009 |
Mechanism-based inactivation of human cytochrome P450 2B6 by clopidogrel: involvement of both covalent modification of cysteinyl residue 475 and loss of heme.
Topics: Aryl Hydrocarbon Hydroxylases; Base Sequence; Chromatography, High Pressure Liquid; Clopidogrel; Cysteine; Cytochrome P-450 CYP2B6; DNA Primers; Enzyme Inhibitors; Heme; Humans; Kinetics; Mutagenesis, Site-Directed; Oxidoreductases, N-Demethylating; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Ticlopidine | 2011 |